---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-071347"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T08:30:16.456696+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CV Sciences Q1 2025 revenue $3.6M (-10% YoY); turns operating profit $11K

## Summary
- Q1 revenue $3.6M vs $4.0M YoY; unit volume down 11.8%, partially offset by 0.9% price increase.
- Operating income of $11K vs $0.6M loss YoY, boosted by $0.5M reversal of accrued payroll taxes.
- Adjusted EBITDA loss improved to $0.3M from $0.5M YoY; gross margin 46.0% vs 46.3%.
- Launched Lunar Fox plant-based product line with 7 vegan products in U.S. retail and online.
- Raised $1.2M net from institutional investor in Q1; cash balance $0.8M vs $0.5M end-2024.

## SEC filing metadata
- accession: 0000950170-25-071347
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/0000950170-25-071347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/cvsi-20250514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-071347
- JSON: https://secwatch.observer/filing/0000950170-25-071347.json
- Plain text: https://secwatch.observer/filing/0000950170-25-071347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
